Skip to the main content
Cheque Size$100K to $2M
Stages7
Industries21
Markets20
Stated Portfolio1
Operating Since2010 (16y)

About Roquette Ventures

Roquette Ventures is the corporate venture capital arm of Roquette, a global leader in plant-based ingredients and pharmaceutical excipients. Established in 2010, Roquette Ventures focuses on strategic investments in startups that drive growth and technological advancement in the food and nutrition industries. By leveraging Roquette's extensive expertise, the firm aims to accelerate the development of pioneering innovations that unlock the potential of nature. The investment strategy of Roquette Ventures centers on supporting inspiring and forward-looking teams worldwide. The firm seeks projects that develop cutting-edge solutions across the entire value chain of the Pharma and Food & Nutrition markets. Key areas of interest include innovative drug delivery methods, plant-based ingredients offering nutritional and functional benefits, high-performing plant-based specialties for cosmetics, breakthrough manufacturing technologies, and reimagined business models for bringing plant-based innovations to market. Roquette Ventures has a track record of investing in companies that align with its strategic focus. Notably, the firm invested in Biograil ApS, a startup revolutionizing the oral delivery of biologics. This investment underscores Roquette Ventures' commitment to fostering growth and technological advancement in the food and nutrition sectors, supporting companies that are at the forefront of innovation and sustainability.

Geographical Focus

African markets2

Other stated markets18

United StatesUnited KingdomCanadaGermanyJapanAustraliaChinaIndiaBrazilFranceItalySpainMexicoSouth KoreaTurkeyRussiaChileArgentina

Requirements

Innovative solutions disrupting traditional drug delivery, Plant-based ingredients offering nutritional and functional benefits, High-performing plant-based specialties for cosmetics markets, Breakthrough technologies improving manufacturing processes, Reimagined business models for plant-based innovations

Stated Portfolio1

Biograil ApS

As reported by the investor. We hold no profile for this company, so it is printed as stated rather than linked.